news

The Year Strategy Meets Scale: Brillio’s Beyond the Curve 2026 Charts the Enterprise AI Roadmap

DALLAS, Feb. 3, 2026 /PRNewswire/ -- Brillio today unveiled Beyond the Curve 2026, a flagship outlook that reframes the AI agenda for…

2 weeks ago

Role of CathWorks FFRangio for the Assessment of Coronary Artery Disease Now Reinforced by SCAI Expert Opinion

NEWPORT BEACH, Calif., Feb. 3, 2026 /PRNewswire/ -- CathWorks, a global leader in digital health innovations, announced that the Society…

2 weeks ago

Metabolon Names Andrew Messick Chief Financial Officer

Seasoned life sciences finance leader brings deep expertise in operational excellence and M&A to support Metabolon's next stage of growthMORRISVILLE,…

2 weeks ago

NYSE Content Advisory: Pre-Market Update + AstraZeneca Climbs Nearly 1% After Historic NYSE Transfer

NEW YORK, Feb. 3, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

2 weeks ago

Skin Aesthete Becomes Navi Mumbai’s Only Clinic to Offer EMFACE, Redefining Non-Invasive Facial Rejuvenation

MUMBAI, India, Feb. 3, 2026 /PRNewswire/ -- Skin Aesthete, the premium dermatology and aesthetics clinic founded by Dr. Sonal Ahuja,…

2 weeks ago

21 Asian Countries Among 93 Worldwide at Risk of Losing Nearly 23 Million More People by 2030

ISGlobal, supported by Rockefeller Foundation, analyzed impact of severe global aid cuts in 93 countries, with 21 in AsiaNew study…

2 weeks ago

Berry Street Named to 2026 New York Digital Health 100 List

Digital Health New York recognizes nutrition therapy platform’s innovative approach to evidence-based nutrition care February 03, 2026 13:43 ET  |…

2 weeks ago

Neomorph Announces First Patient Dosed in Phase 1/2 Trial Evaluating NEO-811 For the Treatment of Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

Initiation of trial marks first-in-human milestone for Neomorph’s novel molecular glue degrader platform February 03, 2026 13:08 ET  | Source:…

2 weeks ago

RESTEM Announces First Patient Dosed in the Phase 2/3 IIMPACT Study of Restem-L in Idiopathic Inflammatory Myopathy

February 03, 2026 13:06 ET  | Source: Restem Initiation of the IIMPACT study follows promising Phase 1 results where Restem-L…

2 weeks ago

Cango Inc. Announces January 2026 Bitcoin Production and Mining Operations Update

DALLAS, Feb. 3, 2026 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company"), a leading Bitcoin miner leveraging its…

2 weeks ago